Zolpidem (Ambien® and generic, Ambien CR® and generic, Edluar®, Intermezzo® and generic, and Zolpimist) is a gamma-aminobutyric acid (GABA) A agonist that is used as a hypnotic. Here is basic information about this medication.
A. Short-term treatment of insomnia characterized by difficulty in sleep initiation
Oral tablet (Ambien® and generic), sublingual tablet (Edluar®), or oral spray (Zolpimist®) may be indicated
B. Treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep
Low-dose zolpidem sublingual tablet (Intermezzo® and generic) may be indicated
C. Treatment of insomnia characterized by difficulties with sleep initiation and/or sleep maintenance
Extended-release oral tablet (Ambien CR® and generic) may be indicated
1. Short-term treatment of insomnia characterized by difficulty in sleep initiation
a. Oral tablet (Ambien®) or sublingual tablet (Edluar®)
Initial: 5 mg (women), 5 or 10 mg (men) once daily at bed time
Maximum: 10 mg once daily at bed time
b. Oral Spray (Zolpimist®)
Initial: 10 mg (2 sprays) once daily at bedtime
Maximum: 10 mg once daily at bedtime
2. Treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep
Low-dose sublingual tablet (Intermezzo®): 1.75 mg (women), 3.5 mg (men)
Note: Indicated only if more than four hours remain before the planned time of waking
3. Treatment of insomnia characterized by difficulties with sleep maintenance and/or sleep initiation
Extended-release tablet (Ambien CR®)
Initial: 6.25 mg (women), 6.25 mg or 12.5 mg (men) once daily at bed time
Maximum: 12.5 mg once daily at bedtime
Special Considerations: In elderly, debilitated, and patients with hepatic impairment start with the lowest dose (refer to prescribing information for details)
Dosage forms and strengths
Oral tablet (Ambien®): 5 mg, 10 mg
Sublingual tablet (Edluar®): 5 mg, 10 mg
Extended-release tablet (Ambien CR®): 6.25 mg, 12.5 mg
Oral Spray (Zolpimist®): Each spray (metered actuation) delivers 5 mg zolpidem in 0.1 mL
Low-dose sublingual tablet (Intermezzo®): 1.75 mg and 3.5 mg
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Copyright 2016, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.